PFM Health Sciences’s U.S. SILICA HOLDINGS, INC. SLCA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q2
Sell
-1,350,636
Closed -$64.8M 118
2017
Q1
$64.8M Buy
1,350,636
+493,765
+58% +$26.4M 1.62% 22
2016
Q4
$48.6M Buy
856,871
+435,023
+103% +$21.5M 1.37% 25
2016
Q3
$19.6M Buy
421,848
+39,507
+10% +$1.54M 0.58% 57
2016
Q2
$13.2M Buy
+382,341
New +$10.6M 0.4% 64

Other funds holding SLCA

PFM Health Sciences's SLCA Position: Q2 2017 in Review

PFM Health Sciences sold out of U.S. SILICA HOLDINGS, INC. (SLCA) in Q2 2017, closing a stake of 1,350,636 shares — an estimated $64.8M sold.

PFM Health Sciences first reported a position in SLCA in Q2 2016 and held it in 4 quarters. The position peaked at $64.8M in Q1 2017. 308 funds tracked by Wall St. Rank hold SLCA as of Q2 2017.

  • PFM Health Sciences reported no remaining U.S. SILICA HOLDINGS, INC. position as of Q2 2017 after selling out during the quarter.
  • PFM Health Sciences sold 1,350,636 U.S. SILICA HOLDINGS, INC. shares in Q2 2017, an estimated $64.8M.
  • PFM Health Sciences first reported a position in U.S. SILICA HOLDINGS, INC. in Q2 2016 and held it in 4 quarters.
  • PFM Health Sciences's U.S. SILICA HOLDINGS, INC. position peaked at $64.8M in Q1 2017.
  • 308 funds tracked by Wall St. Rank held U.S. SILICA HOLDINGS, INC. as of Q2 2017.

Based on PFM Health Sciences's 13F filing for Q2 2017, filed 14 Aug 2017.